about
Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein traffickingThe Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsThe elements of life and medicinesPaxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancerPreparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats.Co-delivery of carboplatin and paclitaxel via cross-linked multilamellar liposomes for ovarian cancer treatment.Nanocarriers for delivery of platinum anticancer drugs.Cisplatin loaded albumin mesospheres for lung cancer treatment.Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacyMultifunctional, stimuli-sensitive nanoparticulate systems for drug deliveryEGFR Targeted Theranostic Nanoemulsion for Image-Guided Ovarian Cancer Therapy.Ligand-targeted theranostic nanomedicines against cancerMolecular imaging of brain localization of liposomes in mice using MALDI mass spectrometry.Science and technology of the emerging nanomedicines in cancer therapy: A primer for physicians and pharmacists.Two consecutive days of treatment with liposomal cisplatin in non-small cell lung cancerNanotechnology and Pediatric Cancer: Prevention, Diagnosis and TreatmentNanotechnology applications in thoracic surgery.Liposomes, a promising strategy for clinical application of platinum derivatives.Therapeutic nanoparticles in clinics and under clinical evaluation.Current trends in the use of liposomes for tumor targetingApplication of liposomal technologies for delivery of platinum analogs in oncology.Driving forces for drug loading in drug carriers.Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer.Cancer drug delivery in the nano era: An overview and perspectives (Review)Nanoparticle formulations of cisplatin for cancer therapy.Prodrug-based nano-drug delivery system for co-encapsulate paclitaxel and carboplatin for lung cancer treatment.Preparation, characterization, and cytotoxic effects of liposomal nanoparticles containing cisplatin: an in vitro study.Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells.Multifunctional platinum-based nanoparticles for biomedical applications.Trends on polymer- and lipid-based nanostructures for parenteral drug delivery to tumors.Recent advances in the preparation and application of multifunctional iron oxide and liposome-based nanosystems for multimodal diagnosis and therapy.Convection-enhancement delivery of liposomal formulation of oxaliplatin shows less toxicity than oxaliplatin yet maintains a similar median survival time in F98 glioma-bearing rat model.A Combination RNAi-Chemotherapy Layer-by-Layer Nanoparticle for Systemic Targeting of KRAS/P53 with Cisplatin to Treat Non-small Cell Lung Cancer.Nanomedicine applications in the treatment of breast cancer: current state of the art.Octreotide labeled aggregates containing platinum complexes as nanovectors for drug delivery.Phospholipid-mimic oxaliplatin prodrug liposome for treatment of the metastatic triple negative breast cancer.Nanomaterials as nanocarriers: a critical assessment why these are multi-chore vanquisher in breast cancer treatment.Nanoparticles: the future for platinum drugs or a research red herring?Polymeric micelles for targeted tumor therapy of platinum anticancer drugs.Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells.
P2860
Q27011482-A40EF9EC-E29D-4DD1-8FA9-D105C517FCD9Q28066801-87BE6B77-BFB6-4A41-8CA3-03FC3A8B08FFQ28649323-BEE9147A-9C47-42B0-B7CC-5C3E10166D3EQ30542819-CE2BCE2B-A92F-4A36-8D94-830E3CBC3F7AQ31106992-F896CDF9-BD4E-4A98-BA67-8BD86FDEFAC8Q33742311-27647304-C43E-42F1-8E64-DA791064248BQ34338695-9D0C94CB-7217-412C-AF60-D9A46F23BC26Q35402288-7558BDA5-4273-4754-90C0-7A51B3B3D5CFQ35679856-5870DE26-7907-4070-BF1A-90E4517B0A2FQ35809872-808BC6A6-F431-416C-9E3C-752C18348DEDQ35812462-9A25933C-801B-4BC9-93B4-C131DB371EB5Q35895637-78A11863-A34D-40E7-8821-85507A6AE8A7Q36138874-6533D37E-DC87-48B5-870E-B6F1CCAD14A8Q36394925-5EE05352-3052-4DB3-96C6-258015202391Q36403215-4606650A-01D9-42CD-909A-3AF79E97631EQ36654099-953845FA-024E-499A-BC84-FE82F16EF76DQ37021105-CFB6E0D0-01B8-45EA-9521-26A18D36ACE7Q38087423-36E739A0-8305-4A87-B877-3E59080EF053Q38087986-A0BA64F1-2DA3-4AC9-ABED-8B3CF0A64927Q38126543-A3F319F4-E68B-43F5-9CD7-8C9429280DD8Q38136184-F62B3CBF-0F4C-4CE1-AEBC-44EEDD3C8AC2Q38366771-FAB8CFFB-1A8A-4FDF-98BB-F8FA3EBFB574Q38633157-3AFCD064-4E87-4469-812A-AD60658941EAQ38669454-6C24166F-EE40-4EBD-BE53-A59B34C7292EQ38723829-65193957-C11C-47E1-B3C7-0A46B3BA05CEQ38741016-B23D8F06-C47D-4E34-8728-8AF77A78BF99Q38771030-DF4D2D9D-9E94-4168-8C91-0C18005163C9Q38796115-D5C081B1-3F1D-41FF-9D24-ADDE7198F82EQ38812240-64B3FCA0-6A93-4AE3-9F98-338C9FF0CC7AQ38981743-75597E21-839D-4B98-89A1-AE673C628138Q39030223-86E6B259-C221-478F-AD0E-06B60DDFBDF9Q39550844-24A5F39A-3A7C-4067-A896-AA7465FBA8D2Q40040290-8FF36D42-F5AD-4233-9D00-BE38BDBFB916Q41483629-AF7738A1-EB1A-4FB2-AF97-917AD04F87EFQ44374131-5D0DBBE3-94C0-4850-928A-7A424C9D5215Q48280114-2D9956BF-CEF9-4567-8463-663986D193D8Q50072050-2297BA10-2103-4FD1-AF52-32D7345BAACAQ50503240-A729931B-50AC-49FA-8FAB-D0AC9D1D0C04Q50960383-92E23B05-CF51-43FB-815B-86F008015E65Q52571253-445FACB5-9A1B-4703-80D8-DC958359BFDF
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Lipoplatin formulation review article.
@ast
Lipoplatin formulation review article.
@en
Lipoplatin formulation review article.
@nl
type
label
Lipoplatin formulation review article.
@ast
Lipoplatin formulation review article.
@en
Lipoplatin formulation review article.
@nl
prefLabel
Lipoplatin formulation review article.
@ast
Lipoplatin formulation review article.
@en
Lipoplatin formulation review article.
@nl
P2860
P356
P1476
Lipoplatin formulation review article.
@en
P2093
G P Stathopoulos
T Boulikas
P2860
P304
P356
10.1155/2012/581363
P577
2011-08-29T00:00:00Z